Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neuroscientific Biopharmaceuticals Ltd. (AU:NSB)
ASX:NSB
Holding AU:NSB?
Track your performance easily
NSB Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.03 - AU$0.08
Previous CloseAU$0.04
Volume61.63K
Average Volume (3M)279.71K
Market Cap
AU$5.80M
Enterprise Value-AU$1.72M
Total Cash (Recent Filing)AU$7.22M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)17.3
Beta-0.06
Next Earnings
Mar 03, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares OutstandingN/A
10 Day Avg. Volume94,703
30 Day Avg. Volume279,706
Standard Deviation0.19
R-Squared0.00191
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Neuroscientific Biopharmaceuticals Ltd. News
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Secures Key Resolutions at AGM
PremiumCompany Announcements
NeuroScientific Advances in Glaucoma Treatment Research
PremiumCompany Announcements
Neuroscientific Biopharma Sets Date for 2024 AGM
PremiumCompany Announcements
Neuroscientific Biopharma Complies With Governance Standards
PremiumCompany Announcements
NeuroScientific Posts Higher Annual Profit
PremiumCompany Announcements
NeuroScientific Advances Glaucoma TreatmentNSB FAQ
What was Neuroscientific Biopharmaceuticals Ltd.’s price range in the past 12 months?
Neuroscientific Biopharmaceuticals Ltd. lowest share price was AU$0.03 and its highest was AU$0.08 in the past 12 months.
What is Neuroscientific Biopharmaceuticals Ltd.’s market cap?
Currently, no data Available
When is Neuroscientific Biopharmaceuticals Ltd.’s upcoming earnings report date?
Neuroscientific Biopharmaceuticals Ltd.’s upcoming earnings report date is Mar 03, 2025 which is in 113 days.
How were Neuroscientific Biopharmaceuticals Ltd.’s earnings last quarter?
Neuroscientific Biopharmaceuticals Ltd. released its earnings results on Aug 29, 2024. The company reported AU$0.011 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.011.
Is Neuroscientific Biopharmaceuticals Ltd. overvalued?
According to Wall Street analysts Neuroscientific Biopharmaceuticals Ltd.’s price is currently Overvalued.
Does Neuroscientific Biopharmaceuticals Ltd. pay dividends?
Neuroscientific Biopharmaceuticals Ltd. does not currently pay dividends.
What is Neuroscientific Biopharmaceuticals Ltd.’s EPS estimate?
Neuroscientific Biopharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neuroscientific Biopharmaceuticals Ltd. have?
Neuroscientific Biopharmaceuticals Ltd. has 144,604,870 shares outstanding.
What happened to Neuroscientific Biopharmaceuticals Ltd.’s price movement after its last earnings report?
Neuroscientific Biopharmaceuticals Ltd. reported an EPS of AU$0.011 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Neuroscientific Biopharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in AU:NSB
---
Neuroscientific Biopharmaceuticals Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.66%
12-Months-Change
Fundamentals
Return on Equity
6.46%
Trailing 12-Months
Asset Growth
2.74%
Trailing 12-Months
Company Description
Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd is an Australian based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.
---
Technical Analysis
LBT Innovations Limited
―
Noxopharm Ltd.
―
PYC Therapeutics Limited
―
Alcidion Group Limited
―
---